Narayana Hrudayalaya Limited

NSE NH.NS

Narayana Hrudayalaya Limited Gross Profit for the year ending March 31, 2024: USD 146.70 M

Narayana Hrudayalaya Limited Gross Profit is USD 146.70 M for the year ending March 31, 2024, a -35.30% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Narayana Hrudayalaya Limited Gross Profit for the year ending March 31, 2023 was USD 226.73 M, a 2.50% change year over year.
  • Narayana Hrudayalaya Limited Gross Profit for the year ending March 31, 2022 was USD 221.21 M, a 59.00% change year over year.
  • Narayana Hrudayalaya Limited Gross Profit for the year ending March 31, 2021 was USD 139.13 M, a -22.34% change year over year.
  • Narayana Hrudayalaya Limited Gross Profit for the year ending March 31, 2020 was USD 179.14 M, a 5.87% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
NSE: NH.NS

Narayana Hrudayalaya Limited

CEO Dr. Emmanuel Rupert
IPO Date Jan. 6, 2016
Location India
Headquarters 261/A, Bommasandra Industrial Area
Employees 11,659
Sector Health Care
Industries
Description

Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Similar companies

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.39

-1.98%

SYNGENE.NS

Syngene International Limited

USD 9.56

0.73%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

ASTERDM.NS

Aster DM Healthcare Limited

USD 5.77

1.93%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 20.35

-1.23%

StockViz Staff

January 15, 2025

Any question? Send us an email